Comparison of the number of patients needed to treat with abciximab, eptifibatide and tirofiban to prevent death or myocardial infarction

被引：0
|
作者：
Wilson, MG
Jamal, HH
Wischet, W
Reid, P
机构：
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3552
引用
收藏
页码：650 / 650
页数：1
相关论文
共 50 条
  • [11] Comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary interventions
    Changezi, H
    Schweiger, MJ
    Prescod, D
    Cook, JR
    CIRCULATION, 1999, 100 (18) : 187 - 187
  • [12] Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial
    Marzocchi, Antonio
    Manari, Antonio
    Piovaccari, Giancarlo
    Marrozzini, Cinzia
    Marra, Sebastiano
    Magnavacchi, Paolo
    Sangiorgio, Pietro
    Marinucci, Lucia
    Taglieri, Nevio
    Gordini, Giovanni
    Binetti, Nicola
    Guiducci, Vincenzo
    Franco, Nicoletta
    Reggiani, Maria Letizia-Bacchi
    Saia, Francesco
    EUROPEAN HEART JOURNAL, 2008, 29 (24) : 2972 - 2980
  • [13] Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention and Abciximab or Tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)
    Taglieri, Nevio
    Saia, Francesco
    Guiducci, Vincenzo
    Tondi, Stefano
    Conrotto, Federico
    Marrozzini, Cinzia
    Rocchi, Guido
    Biagini, Elena
    Reggiani, Maria Letizia Bacchi
    Giacometti, Paola
    Piovaccari, Giancarlo
    Manari, Antonio
    Marzocchi, Antonio
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (06) : 785 - 790
  • [14] Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions
    Midei, Mark G.
    Coombs, Vicki J.
    Lowry, David R.
    Drossner, Michael N.
    Prewitt, Kerry C.
    Wang, John C.
    Loughrey, Michele B.
    Gottlieb, Sidney O.
    CARDIOLOGY, 2007, 107 (03) : 172 - 177
  • [15] Number needed to treat in indirect treatment comparison
    Guyot, Patricia
    Cheng, Wei
    Tremblay, Gabriel
    Copher, Ronda
    Burnett, Heather
    Li, Xuan
    Makin, Charles
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (03) : 259 - 269
  • [16] Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
    Harms, Maren H.
    de Veer, Rozanne C.
    Lammers, Willem J.
    Corpechot, Christophe
    Thorburn, Douglas
    Janssen, Harry L. A.
    Lindor, Keith D.
    Trivedi, Palak J.
    Hirschfield, Gideon M.
    Pares, Albert
    Floreani, Annarosa
    Mayo, Marlyn J.
    Invernizzi, Pietro
    Battezzati, Pier Maria
    Nevens, Frederik
    Ponsioen, Cyriel Y.
    Mason, Andrew L.
    Kowdley, Kris V.
    Hansen, Bettina E.
    van Buuren, Henk R.
    van der Meer, Adriaan J.
    GUT, 2020, 69 (08) : 1502 - 1509
  • [17] Triptans for migraine therapy: A comparison based on number needed to treat and doses needed to treat
    Mullins, CD
    Weis, KA
    Perfetto, EM
    Subedi, P
    Healey, PJ
    VALUE IN HEALTH, 2005, 8 (03) : 318 - 318
  • [18] Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Coronary Angioplasty and Abciximab or Tirofiban: Insights From the Facilitated Angioplasty with Tirofiban or Abciximab (FATA) Randomized Trial
    Taglieri, Nevio
    Saia, Francesco
    Marrozzini, Cinzia
    Guiducci, Vincenzo
    Rocchi, Guido
    Biagini, Elena
    Piovaccari, Giancarlo
    Manari, Antonio
    Branzi, Angelo
    Marzocchi, Antonio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A326 - A327
  • [19] Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction
    Raveendran, Ganesh
    Ting, Henry H.
    Best, Patricia J.
    Holmes, David R., Jr.
    Lennon, Ryan J.
    Singh, Mandeep
    Bell, Malcolm R.
    Long, Kirsten Hall
    Rihal, Charanjit S.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (02) : 196 - 202
  • [20] Tirofiban, eptifibatide, and abciximab in minimizing myocardial damage during high-risk coronary intervention: Final results of the TEAM pilot trial
    Sharma, SK
    Kini, AS
    Perez, N
    Suleman, J
    Fisher, EA
    Marmur, JD
    Richard, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 73A - 73A
12345